Cingulate Inc. Common Stock, Value, Issued
Cingulate Inc. (CING) had Common Stock, Value, Issued of $1.39 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-13
- 2026-06-30: Common Stock, Value, Issued $1.39K.
- 2026-03-31: Common Stock, Value, Issued $1.19K.
- 2025-12-31: Common Stock, Value, Issued $725.00.
- 2025-09-30: Common Stock, Value, Issued $596.00.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $1.39K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.19K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $725.00 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $596.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $488.00 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $382.00 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $340.00 10-K · filed 2026-03-18 | |
| 2024-09-30 | $305.00 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $78.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $502.00 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $10.00 10-K · filed 2025-03-27 | $118.00 10-K · filed 2024-04-01 |
| 2023-09-30 | $1.74K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.21K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.13K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $61.00 10-K · filed 2024-04-01 | $1.13K 10-K · filed 2023-03-10 |
| 2022-09-30 | $1.13K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.13K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.13K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.13K 10-K · filed 2023-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |